NEWEarnings
Pfizer (PFE) Lacks Earnings Momentum According to Analyst Jim Cramer
Published on 5/14/2026

AI Summary
Analyst Jim Cramer stated that Pfizer (PFE) does not have any current earnings momentum. This observation could indicate potential concerns regarding PFE’s future stock performance in the market. Without positive earnings momentum, investor confidence may decline, potentially affecting the stock's valuation. It is essential for investors to monitor PFE's earnings reports closely to gauge any changes in momentum.
Related News

Earnings
Law Debenture (LWDB) Declares First Interim Dividend of 8.875p
May 14

Earnings
Dream Unlimited (DRM) reports improved margins in Q1 2026 earnings
May 14

Earnings
Elemental Royalties Corp (ELE) Q1 2026 Revenue Hits Record Levels
May 14

Earnings
Capital Southwest (CSWC) Q1 2026 EPS Beats Forecast by 10%
May 14